跳至主要内容
临床试验/NCT03704623
NCT03704623已完成4 期

Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic Due to Ureteric Calculi: Randomized Controlled Trial

Mansoura University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
200
试验地点
1
主要终点
The need for rescue analgesia (Morphine)

研究概览

简要总结

This study will be conducted to compare the efficacy and safety of Parecoxib versus Paracetamol for treatment of acute renal colic due to ureteric stones.

详细描述

Eligible patients will be randomized to one of the two treatment groups. Group 1 patients will receive IV 1 g of Paracetamol while group 2 patients will receive 40 mg of Parecoxib IV.

The Visual Analogue Scale (VAS) will be calculated on presentation and at 30 minutes after analgesia administration. Patients who do not respond to an initial dose of the analgesia will receive rescue analgesia in the form of Morphine, 01.mg/kg, IV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

The emergency department (ED) nurse will do randomization by drawing one of the sealed closed envelopes that contain the analgesic to be administered.

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical signs and symptoms consistent with acute renal colic

排除标准

  • Hypersensitivity to either Paracetamol or Parecoxib.
  • History of peptic ulcer.
  • Pregnant or breastfeeding females.
  • Patients with hepatic impairment (Child-Pugh score >10).
  • Patients with chronic kidney disease (CKD) Stage 4 or 5 (eGFR <30mls/min).
  • History of coronary ischemia, peripheral vascular or cerebrovascular disease.

研究组 & 干预措施

Paracetamol

Active Comparator

Patients will receive IV 1 g of Paracetamol

干预措施: Paracetamol (Drug)

Parecoxib

Active Comparator

Patients will receive 40 mg of Parecoxib IV

干预措施: Parecoxib (Drug)

结局指标

主要结局

The need for rescue analgesia (Morphine)

时间窗: 30 minutes

Patient who had persistent pain

次要结局

  • The incidence of adverse effects due to medication used(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed R. EL-Nahas

Professor of Urology

Mansoura University

研究点 (1)

Loading locations...

相似试验

Parecoxib vs Paracetamol in the Treatment of Acute... | 临床试验